Indian Journal of Transplantation is the official journal of the Indian Society of Organ Transplantation with Editorial Office situated at Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh. Indian Journal of Transplantation is published quarterly in March, June, September and December by Elsevier India. Through this journal, the society aims to provide experienced insights and reviews regarding liver, kidney, bone marrow, heart and lung transplantations to the readers. The journal also provides transplant practitioners and researchers an opportunity to share valuable, experienced and recent views about organ transplantations with fellow medical practitioners, post graduate students, educational institutions, libraries and hospitals. Indian Journal of Transplantation is circulated to over 1000 readers in the Organ Transplant community in India and abroad.
Regular Articles are full-length papers that address research questions with exhaustive study design and methodology. The entire manuscript including abstract and references should not exceed 15 typed pages in double space and should not contain more than 30 references.
Brief Communications should not contain more than 2000 words (including abstract, figures, tables and references) describing important new observations in transplantation.Review of basic and clinical topics of interest to the readership will be solicited by the editors. The length of review articles should not exceed fifteen typed pages.
Case reports should be limited to 1200 words, should not have more than 4 authors and should not contain over 2 illustrations and 10 references. Case reports submitted as 'Case Report and Review of Literature', must also conform to these rules.Letters to the editor containing interesting observations and comments on the articles published in the journal are welcome for publication. Due care should be taken in the formation of the letter to avoid any misunderstanding. The replies to such letters will also be published as and when received from the authors. The letter and the reply should not exceed 300 words and should not contain more than 5 references.
The manuscript would be forwarded to an associate editor and two reviewers. Manuscripts that are outside the range of interest of Indian Journal of Transplantation readership or that fail to satisfy the technical requirements would be rejected and promptly returned to authors without further review. The rejected manuscripts would be destroyed. Manuscripts returned to authors for modification should be returned back to editorial office as early as possible but not later than 3 months, after which the article would be filed and not considered for publication. The editorial board reserves the right to assess suitability of the language, modify the letter and text, and improve the photographs and illustrations to enhance clarity of expression and presentation without affecting the message and meaning being conveyed by the article.
Contact details for submission
If assistance is required by the authors, please refer to the tutorials for authors and/or customer support that are available on the EVISE website; you may also contact the Editorial Office. Please do not post, fax or e-mail your manuscripts to the Editorial Office.
Dr. RK Sharma
Professor and Head, Department of Nephrology,
Sanjay Gandhi Postgraduate Institute of Medical Sciences,
Rae Bareli Road, Lucknow, Uttar Pradesh 226 014, India.
Phone: +91-522-2668700 Ext: 2121
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• Relevant declarations of interest have been made
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Manuscripts submitted to Indian Journal of Transplantation should not have been published previously or be under simultaneous consideration for publication by any other journal. Violation may lead to a retraction of the published article by the Journal and other actions as deemed necessary by the editor. All articles (including those invited) will be peer-reviewed, and accepted articles will be edited to the Journal's style. Accepted manuscripts become the permanent property of the Journal and may not be reproduced, in whole or in part, without the written permission of the editor. Studies involving human subjects or animals should have received the approval of the institutional ethics committee. A statement to this effect and that informed consent was obtained from participating human subjects must be included in the manuscript text.
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Ethical approval of studies and Informed consent
Studies involving human subjects or animals should have received the approval of the institutional ethics committee. A statement to this effect and that informed consent was obtained from participating human subjects must be included in the manuscript text. Please ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
IJT follows the ICMJE recommendations regarding conflict of interest disclosures. All authors are required to report the following information with each submission: (1) All third-party financial support for the work in the submitted manuscript. (2) All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript. (3) All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission. (4) Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued). (6) Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not. This information will be acknowledged at publication in a Transparency Document link directly in the article. Additional information on the ICMJE recommendations can be found at: http://www.icmje.org/. The form for conflict of interest disclosure can be downloaded here: http://www.icmje.org/coi_disclosure.pdf (if this link does not display properly in your browser, please right-click the link and select "Save Target As..." or "Save Link as..." from the pop-up menu).
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck.
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. Please give contribution of each author on the cover page of the manuscript.
Changes to Authorship
Ideally there should not be any change in authorship after the manuscript is submitted. In situations where there has been an omission or substantial work is done when the article is revised, an author's name may be added. This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed upon by the editor.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart (please go to http://www.consort-statement.org for more information). The IJT has adopted the ICMJE proposal that requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.
For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at http://www.icmje.org.
Indian Journal of Transplantation is the official peer-reviewed journal of the Indian Society of Organ Transplantation. Manuscripts published in the IJT become the permanent property of the Indian Society of Organ Transplantation. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No IJT article, in part or whole, may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from Indian Society of Organ Transplantation.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Find out how you can share your research published in Elsevier journals.
As an author you (or your employer or institution) have certain rights to reuse your work. For more information see http://www.elsevier.com/copyright.
All financial and material support for the research, work, writing and editorial assistance from internal or external agencies, including commercial companies, should be clearly and completely identified in a Funding/Support Statement. You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information. Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 12 months.
Articles should be written in English, using American English spelling. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop http://webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information.
Identification of patients in descriptions, photographs and pedigrees
A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all persons (parents or legal guardians for minors) who can be identified (including by the patients themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
The Journal only accepts online submissions in electronic format. All new manuscripts must be submitted through Indian Journal of Transplantation online and review website (https://www.evise.com/evise/jrnl/IJT). Please follow the following steps to submit your manuscript:
1. Open the homepage of the Journal's website https://www.evise.com/evise/jrnl/IJT.
2. Register yourself for free by clicking on register on the top and create a user profile with a desired username and mandatory details. On submission of the information, you will receive an email confirming your registration along with the "Password"
3. Click "Log In" on the main navigation menu at the top of the journal screen to open the login page.
4. Enter your username and password in the appropriate fields (e-mailed to you at the time of registration).
5. Click "Author Log in", this takes you to the "Author Main Menu".
6. After that you can submit the manuscript by following the instructions provided on the screen.
7. Revised manuscripts can be uploaded online using the same log in.
If you have any problems in submission of your manuscript, please send us an email at firstname.lastname@example.org.
Note : Please note that the username and password combination required for Elsevier Editorial System is different from your username and password combination used to "Track your paper" on the Elsevier "Authors' Home" website.By submitting a manuscript online, the author agrees to the following:
1. The work is original and free from plagiarism.
2. It has neither been published, nor is it not under consideration for publication at another journal.
3. All authors are aware of the authorship order. The corresponding author shall be responsible in case of dispute.
4. Once published, copyright of manuscript shall stand transferred to the Journal.
5. "Conflict of interest" if any, must be explicitly stated at the end of the manuscript.
Submit your article
Please submit your article via https://www.evise.com/evise/jrnl/IJT.
Manuscripts must conform to the instructions given below:
Type the manuscript using 'Times New Roman' font, size 12 in double space throughout. Please arrange the manuscript as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, and References. Number all pages consecutively, beginning with the title page. All figures and Tables must be referred to in the manuscript. Consult a recent issue of the Journal for details. Only the Title page should bear the names and addresses of the author(s). Editorials, perspective and review articles are generally by invitation. However if you are interested in writing a review/perspective, you can send an email to the editor with the topic and a short summary of contents to be included. The editor will convey her decision in 7-10 days' time.
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review.
Length of articles
Text of original articles should be between 2000 and 3500 words. The article should not ordinarily contain more than 3 tables, 2 figures and 25 references. Case Reports with an interesting image can be accepted as 'Images in Transplantation'. This report should be of about 750 words including discussion with 1–2 images and 5–6 references. Letters discussing or criticizing material published recently in the Journal, brief presentations of data, or those pertaining to issues of relevance to health policy, practice of medicine, or the like, are welcome. These should not exceed 500 words, 1 table and 5 references.
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
In animal studies, the title should state the species; all other titles will refer to human studies. State names of authors (including first names), the departments and the institution where the work was done. Please do not add your academic qualifications, designation etc. State contribution of each author clearly. A short, running title, not exceeding 40 characters, should be provided. Please provide the name, postal address with PIN code, facsimile number and E-mail address of the author to whom communications and proofs are to be sent. Acknowledgements, if any, may be mentioned on this page.
Original articles should include a structured abstract of upto 250 words under the following headings: Aim, Methods, Results, and Conclusions. [See Ann Intern Med 1990; 113: 69–76]. References should not be included. Upto10 key words, not present in the title, to assist indexing, should be provided below the Abstract in alphabetical order; these may be obtained from the Medical Subject Headings (MeSH) database of National Library of Medicine, USA.
These should appear at the end of the manuscript. The source of funding as well as a disclosure statement mentioning conflict of interest, if any, should appear under this heading. Artwork
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Photographs of 300 dpi or higher resolution may be submitted as 'jpeg', or 'tiff ' files in a zipped folder. In clinical photographs, identity of the subjects should be suitably masked; in case this is not possible, a written permission from the concerned person should accompany the manuscript.
Legends to Figures
The figure number (numbered consecutively in Arabic numerals), title and explanations of the figures should appear in the legend (not on the figure). Type the legends on a separate page. Enough information should be included to interpret the figure without reference to the text.
Each table should be typed on a separate page and numbered consecutively in Arabic numerals. Each table should have a title and all abbreviations should be explained in the footnote. Necessary explanatory notes, if any, may be given below the table.
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
Number the references in the order in which they first appear in the text and identify the reference numbers in the text in superscript. References must be placed at the end of the manuscript. Please use recent references as much as possible. The responsibility for accuracy of references lies with the respective authors. The Journal is in agreement with the International Committee of Medical Journal Editors (http://www.icmje.org). The general arrangement, abbreviations of Journal names and punctuations followed are as per the Uniform Requirements for Manuscripts submitted to Biomedical Journals (http://www.icmje.org). Please pay attention to the style of references and punctuations as follows:
List all authors when six or less as shown in the example below:
Tallon D, Chard J, Dieppe P. Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care and Res 2000; 13: 312–9.[dataset] 5. Oguro, M, Imahiro, S, Saito, S, Nakashizuka, T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1.
When there are seven or more authors, list only the first six and add et al.Book or monograph
Following is an example: Cassidy JT. Juvenile rheumatoid arthritis. In: Textbook of Rheumatology 6th ed, Kelly et al (eds) Philadelphia Saunders 2000; pp. 1297–313.
All articles submitted to the Journal undergo initial review by the Editor/associate editor and articles that are outside the scope of Journal or are not in the journal format are excluded. Later each article is reviewed by at least two reviewers. The time to first decision is usually less than 6 weeks.
Preparation for Publication and Proofs
Once a manuscript has been accepted for publication, authors should submit the final version of their manuscript in MS Word format, with all tables/figures as applicable, via the EVISE. Accepted manuscripts are then copyedited according to the Journal's style and the galley proofs in the form of a PDF file are sent by the Publisher to the corresponding author for final approval. Authors are responsible for all statements made in their work, including changes made by the copy editor.
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download the free Adobe Reader, version 9 (or higher). Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and scan the pages and return via e-mail. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Webshop. Corresponding authors who have published their article open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will be published.